Form 4: Azenta Director William Cornog Acquires Shares Through Board Appointment
SEC Form 4 Filing
Director William Cornog acquired 995 shares of Azenta, Inc. in connection with his appointment to the Board of Directors.
Summary
- William L. Cornog, a director of Azenta, Inc., acquired 995 shares of common stock on November 6, 2024.
- The acquisition was a grant of unrestricted shares related to his appointment to the Board of Directors.
- The price per share was $46.52.
- Following the transaction, Cornog directly owns 2,255 shares of Azenta, Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. A director acquiring shares is generally a good sign, indicating confidence in the company. However, this acquisition is related to his board appointment, so it's not necessarily a strong indicator of personal investment.
Positives
- The acquisition of shares by a director signals confidence in the company's future.
Industry Context
Director share acquisitions are common and are viewed as a positive sign of confidence in the company's prospects.
Comparison to Industry Standards
- Comparing Azenta's director share acquisitions to similar companies like Thermo Fisher Scientific or Danaher Corporation would require analyzing their respective SEC filings for insider trading activity.
- Generally, director share acquisitions are viewed positively if they are purchases made in the open market, indicating personal investment in the company's success.
Key Dates
| Date | Description |
|---|---|
| 11/06/2024 | Date of transaction: William Cornog acquired 995 shares of Azenta, Inc. |
| 11/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.